Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | -.--% | -11.11% | +6.67% |
Business Summary
Number of employees: 11
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Licensing
45.2
%
| - | - | 0 | 45.2 % | - |
Up-front Fees
29.0
%
| - | - | 0 | 29.0 % | - |
Other Services
25.8
%
| - | - | 0 | 25.8 % | - |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
45.2
%
| - | - | 0 | 45.2 % | - |
Canada
29.0
%
| 0 | nan % | 0 | 29.0 % | - |
Other
25.8
%
| - | - | 0 | 25.8 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Amina Odidi
FOU | Founder | - | 01/98/01 |
Isa Odidi
CEO | Chief Executive Officer | - | 01/98/01 |
Comptroller/Controller/Auditor | - | 01/07/01 | |
Corporate Officer/Principal | - | 01/14/01 | |
Patrick Yat
PRN | Corporate Officer/Principal | - | 01/92/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Norman Betts
BRD | Director/Board Member | 68 | 22/19/22 |
Isa Odidi
CEO | Chief Executive Officer | - | 01/98/01 |
Amina Odidi
FOU | Founder | - | 01/98/01 |
Bahadur Madhani
BRD | Director/Board Member | - | 01/06/01 |
Shawn Graham
BRD | Director/Board Member | - | 01/18/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 33,092,665 | 32,511,067 ( 98.24 %) | 0 | 98.24 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
GROWLIFE, INC. 10.84% | 3,662,761 | 10.84% | 7,326 $ |
Company contact information
Intellipharmaceutics International, Inc.
30 Worcester Road
M9W 5X2, Toronto
+416 798 3001
http://www.intellipharmaceutics.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+6.67% | 1.94M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- IPCI.H Stock
- Company Intellipharmaceutics International Inc.